US9045753B2ActiveUtilityPatentIndex 42
siRNA molecule for inhibiting growth of melanin and application thereof
Assignee: JIANGSU GENECON BIOTECHNOLOGIES CO LTDPriority: Oct 27, 2011Filed: Oct 9, 2012Granted: Jun 2, 2015
Est. expiryOct 27, 2031(~5.3 yrs left)· nominal 20-yr term from priority
A61P 35/00C12N 2310/14C12N 15/113A61K 8/606A61K 2800/42A61P 17/00A61Q 19/02
42
PatentIndex Score
0
Cited by
6
References
3
Claims
Abstract
Provided is a double-chain siRNA molecule targeting a microphthalmia-associated transcription factor MITF coding gene. A sense strand of the siRNA molecule has a sequence of SEQ ID NO: 3 and an anti-sense strand has a sequence of SEQ ID NO: 4, and the anti-sense strand specifically binds to mRNA of the MITF coding gene, to degrade the mRNA, thereby reducing the synthesis of melanin. Further provided is an application of the siRNA molecule in freckle whitening cosmetics or the preparation of medicines for treatment of diseases related to melanin gene.
Claims
exact text as granted — not AI-modifiedThe invention claimed is:
1. A double-stranded siRNA molecule, having the following sequences:
(SEQ ID NO: 3)
sense: 5′GGGACACUGAGGAAAGGAGUGGANn-3′
(SEQ ID NO: 4)
antisense: 5′-UCCACUCCUUUCCUCAGUGUCCCNn-3′.
wherein N is deoxythymidine dT; and n is 0 or 2.
2. An application of the siRNA molecule of claim 1 for use in freckle whitening cosmetics.
3. An application of the siRNA molecule of claim 1 for use in the preparation of medicines for treating diseases related to increased melanin.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.